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Abstract 
 Stress is evolutionarily important to survival; however, high levels can lead to adverse 
health outcomes. Stress responses are characterized by the activation of two pathways: the 
hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic division of the autonomic 
nervous system (SNS). These pathways are regulated via a top-down mechanism, where reflexes 
in the brain produce physiological changes elsewhere in the body. Additionally, immune activity 
is closely related to stress, with cytokine markers reacting to SNS activation and entering a 
negative feedback loop with the HPA axis. This research sought to target the top-down 
mechanism of the stress pathways using 10Hz bifrontal Transcranial Alternating Current 
Stimulation (tACS) and investigate resulting changes in alpha amylase (indicator of SNS), 
cortisol (indicator of HPA axis), and a cytokine panel (indicator of immune functioning). 20 
participants underwent 40 minutes of tACS or an active sham condition at two separate sessions 
in a double-blind, randomized, crossover study design. A set of surveys was administered to 
assess overall levels of stress and anxiety, and saliva samples were collected before and after 
stimulation to test for the physiological markers. Results demonstrated an effect of stimulation in 
reducing alpha amylase activity as well as two markers of the cytokine panel, indicating a 
decrease stress and immune response in the verum stimulation condition. This research adds to 
the understanding of the physiological effects of tACS, as well as provides a basis for tACS as a 
possible treatment for individuals with chronic stress. 
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The Effect of 10Hz Transcranial Alternating Current Stimulation on the Stress-Immune 
Response 
Increased stress is commonly associated with decreased immune functioning. Often, 
students complain of poor health during exams or at the height of the semester. But what exactly 
is the nature of the relationship between stress and immunity, and can this relationship be 
manipulated? 
Stress is an evolutionarily advantageous response to triggers that require some sort of 
action, including external cues like predators as well as internal cues like changes in blood 
chemistry (Ulrich-Lai & Herman, 2009; Elenkov & Chrousos, 2002). Furthermore, triggers of 
stress, or stressors, can be either physiological or psychological; and result in the activation of 
two major systems: the autonomic nervous system (ANS) and hypothalamic-pituitary-
adrenocortical (HPA) axis. The ANS can be further divided into the sympathetic and 
parasympathetic divisions, of which the sympathetic nervous system (SNS) is primarily 
responsible for reactions to acute stressors (Ulrich-Lai & Herman, 2009). Commonly referred to 
as the “fight or flight” response, activation of the SNS includes several tangible physiological 
changes, including heart rate elevation, increased sweat secretion, and vasoconstriction of blood 
vessels (Segerstrom & Miller, 2004). Changes brought on by SNS activation can occur within 
seconds, and also revert back to baseline after several minutes once the stressor is alleviated or 
no longer triggering a response (Ulrich-Lai & Herman, 2009). By contrast, HPA axis activation 
happens much more slowly, with a peak occurring more than ten minutes after stressor onset and 
effects lasting up to hours later. Individuals undergoing chronic periods of stress also 
demonstrate higher levels of cortisol, the major hormone associated with the HPA axis, further 
highlighting the time difference between SNS and HPA axis activation.  
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Both of these pathways receive input from the brainstem, which responds to changes in 
homeostasis like respiration, inflammation, pain perception, etc. (Ulrich-Lai & Herman, 2009). 
Upon receiving these signals, the brainstem produces catecholamines and signals to the 
hypothalamus to release corticotropin-releasing hormone (CRH) (Elenkov & Chrousos, 2002). 
CRH production stimulates the adrenal cortex to release cortisol; cortisol then acts on other parts 
of the body to produce physiological changes associated with a stress response, as well as further 
stimulates catecholamine production. The HPA axis and ANS are also subject to top-down 
regulation via limbic structures in the forebrain, including the amygdala, hippocampus, and 
prefrontal cortex, which can excite or inhibit a stress response in reaction to emotional arousal, 
unpleasant memories, or other associations with stressors (Ulrich-Lai & Herman, 2009). Of these 
regions, the prefrontal cortex is thought to be the initiator of top-down regulating activity, given 
its projections to the other limbic structures. 
Similar to stress, the immune system can be broadly categorized into two distinct 
divisions: natural immunity and specific immunity (Segerstrom & Miller, 2004). The 
components of natural immunity are non-specific and are generally considered to the first line of 
defense, as they are activated within minutes in response to invading pathogens. Major cells of 
natural immunity include natural killer (NK) cells, as well as proinflammatory cytokines like 
interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha, which are responsible for general 
immune responses to disease like fever and inflammation. Conversely, a specific immune 
response can take up to days to form, and targets pathogens and diseases based on their 
characteristics. Often, cells involved in specific immunity are triggered by cytokines and natural 
killer cells, and exhibit defense mechanisms that are unique to a particular invading cell.  
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The relationship between stress and immune responses seems to depend on the nature of 
the stressor, and varies based on the type of immune response being considered (Segerstrom & 
Miller, 2004; Marsland, Walsh, Lockwood, & John-Henderson, 2017). Multiple studies 
involving acute stressors, including academic examinations, have shown that short-term stress 
triggers increases in markers of natural immunity, particularly in peripheral levels of NK cells 
and production of IL6 and other cytokines. Chronic stress, however, results in a decrease in 
almost all measures of both natural and specific immunity. Based on these results, two theories 
surrounding the stress-immune relationship have emerged: acute stressors produce adaptive 
changes in immunity, demonstrated by increases in natural immunity markers, while chronic 
stress generates a global suppression of immune functioning.  
Furthermore, immune responses also cause changes in stress. Production of the pro-
inflammatory cytokines, specifically TNF-alpha and IL1 and 6, stimulates the release of CRH 
from the hypothalamus, which in turn triggers the production of cortisol via the HPA axis 
(Elenkov & Chrousos, 2002, Marsland et. al., 2017). Given the inhibitory nature of cortisol and 
general immune functioning, cytokines and cortisol therefore interact through a negative 
feedback loop while the catecholamines stimulate cytokine production during acute stress. 
As stated earlier, the prefrontal cortex is thought to be one of the initial top-down 
regulators of the stress response. Electroencephalogram (EEG) recordings of individuals during 
mindfulness meditation, a technique often used to alleviate stress and anxiety, have demonstrated 
increases in alpha cortical oscillations specifically in the frontal lobe (Lagopoulos et. al., 2009; 
Takahashi et. al., 2005). Cortical oscillations occur endogenously and represent synchronized 
firing of neurons at certain frequencies; alpha oscillations occur between 8-12Hz and are often 
correlated with a relaxed emotional state (Frohlich, 2016). These studies concerning meditation 
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have also recorded heart rate variability, a method of characterizing ANS activity, and found a 
corresponding decrease in SNS activation during these meditative practices.  
Cortical oscillations, including those in the alpha band, can be modulated using 
stimulation techniques like transcranial alternating current stimulation (tACS). TACS is a 
noninvasive technique of enhancing oscillations by applying a weak electrical current at the 
desired frequency (Frohlich, 2016). For example, stimulation applied at 10Hz, or the middle of 
the alpha frequency band, increases alpha oscillations at the location of stimulation. This 
technique has been used successfully in multiple studies with a variety of frequencies and several 
brain regions, as well as specifically to the frontal lobe at 10Hz (Lustenberger, Boyle, Foulser, 
Mellin, & Frohlich, 2015). Therefore, tACS can be used to induce oscillations that occur during 
meditation, potentially serving as a mediator of SNS activation. 
The relationship between stress and immunity has been characterized extensively, but has 
yet to be modulated with an intervention like tACS. I hypothesize that targeting alpha 
oscillations in the frontal cortex via 10Hz tACS will significantly reduce sympathetic activation 
and immune responses to stress compared to an active sham stimulation condition. The results of 
this experiment will contribute to existing literature related to the relationship between stress and 
immune functioning, as well as allow for further exploration involving clinical populations. In 
the future, this research could present a potential treatment option for individuals suffering from 
anxiety and other stress disorders, addressing both the psychological and physiological 
repercussions of such issues. 
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Methods 
This study was a double-blind, randomized, cross-over, sham-controlled, pilot clinical 
trial conducted at The University of North Carolina at Chapel Hill over a 3 month period and 
registered at ClinicalTrials.gov (NCT03178344). This study was approved by the Biomedical 
Institutional Review Board at UNC Chapel Hill (IRB# 16-1911).  
Participants 
A total of 20 healthy individuals participated in this study. The age range was 18-40 years 
(M = 23.2, SD = 6.76). Of the sample, 75% identified as male, and 55% were Caucasian. 
Participants were recruited via advertisements at the University of North Carolina at Chapel Hill, 
including the mass email service disseminated to students and employees as well as flyers posted 
around campus. All potential participants were screened prior to enrolment and were required to 
meet the following criteria: no personal or immediate family history of neurological or 
psychiatric illness, no ongoing psychotherapy treatment or use of medication to treat a 
neurological or psychiatric illness, no major head injury or brain surgery, no brain implants 
(including cochlear implants), no history of cardiovascular disease, and no use of hormonal birth 
control or supplements in the past two weeks. All participants were required to pass a urine drug 
test at the first session, and female participants were additionally require to take a urine 
pregnancy test. Participants were also asked to maintain a regular sleep schedule over the course 
of their participation, as well as abstain from alcohol or caffeine use in the 24 hours prior to each 
visit. Compensation was $30 for each session plus a $20 bonus for completing both study visits. 
Consent was obtained from all participants prior to the start of the first session. 
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Measures 
Salivary Markers. Two saliva samples were collected at both sessions, and were tested for 
alpha-amylase, cortisol, and a cytokine panel (passive drool collection kit, Salimetrics). Alpha-
amylase was used as a substitute for catecholamines to measure SNS activation, and cortisol 
measured HPA activation (Nater, Rohleder, Schlotz, Ehlert, & Kirschbaum, 2007). The cytokine 
panel measured levels of IL1-beta, IL6, IL8, and TNF-alpha.  
Surveys. The Perceived Stress Scale (PSS) is a 14-question measure of the degree to which 
individuals perceive life events as stressful (Cohen, Kamarck, & Mermelstein, 1983). Answers 
can range from ‘0 = Never’ to ‘4 = Very Often.’ The internal consistency coefficient and test-
retest correlation coefficient are both 0.85. 
The Connor-Davidson Resilience Scale (CD-RISC) is a self-report measure of resilience 
consisting of 25 questions, each along a 5-point scale ranging from ‘0 = Not true at all’ to 4 = 
‘True nearly all the time’ (Connor & Davidson, 2003). Total scores range from 0-100, with 
higher scores indicating higher levels of resilience. The internal consistency coefficient for the 
scale is 0.89, and the test-retest correlation coefficient is 0.87. Scores on the CD-RISC are 
negatively correlated with scores on the PSS and Sheehan Stress Vulnerability Scale.  
The State-Trait Anxiety Inventory (STAI) is a measure of both state – or transient – and 
trait anxiety (Spielberger, Gorsuch, Lushene, Vagg, & Jacobs, 1983). Both forms contain 20 
questions with answers ranging from “Almost Never” to “Almost Always.” The internal 
consistency coefficient ranges from 0.86 to 0.95, and the test-retest correlation coefficient is 
0.75.  
Stimulation. Stimulation was administered using a battery-operated stimulator system 
(XCSITE100, Pulvinar Neuro) via three rubber electrodes attached to the scalp using electrically 
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conductive paste (ten20 conductive paste, Weaver & Co.). Electrodes were centered over F3 and 
F4 (5cm x 5cm) and between Pz and Oz (5cm x 7cm); Figure 1 contains a diagram of electrode 
placement. Impedance was kept below 10 kΩ. The verum stimulation condition included 40 
minutes of stimulation at 10Hz and 2 mA amplitude, with 10 seconds of ramp up and 10 seconds 
of ramp down. The sham control stimulation condition followed the same amplitude and 
frequency parameters, with 10 seconds ramp up, 60 seconds of stimulation, and 10 seconds of 
ramp down. All participants watched the video Reefscapes (Undersea Productions, Queensland, 
Australia) for the duration of stimulation at both sessions to keep participants in the same state 
during stimulations. 
Procedures 
Participation included two sessions separated by 5-9 days. Sessions occurred at the same 
time of day to account for circadian fluctuations in cortisol and alpha amylase levels. The study 
was a within-participants crossover design, where all participants received both experimental and 
control stimulation conditions in a randomized order. Blinding was achieved using the “study 
mode” of the XCSITE 100 stimulator. Each participant was assigned a numeric code 
corresponding to a stimulation condition upon enrollment. Codes were generated and 
randomized by a third party with no knowledge of or interest in the outcome of the study. Codes 
were assigned to participants in order of enrollment such that no single participant had a greater 
chance of receiving a particular stimulation order. None of the study personnel were aware of the 
stimulation order of a participant until after sessions were completed. To further ensure blinding, 
all participants completed a questionnaire asking if they thought they had received stimulation at 
the end of each session. Both sessions lasted approximately 3 hours, including electrode 
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application, pre- and post-stimulation recordings and saliva collections, and 40 minutes of 
stimulation.  
Analyses 
Primary Outcomes. The primary outcomes of this study were the changes in salivary markers 
between the two stimulation conditions. All changes were controlled for baseline variation by 
converting the post-stimulation value to a percentage of the baseline, and then log-adjusted to fit 
a normal distribution. To test the main hypothesis, a 2 x 2 within-subjects analysis of variance 
(ANOVA) was conducted with the main effects session (first or second) and condition (verum or 
sham). The interaction effect of session x condition tested for an effect of sequence, or order of 
stimulation. This ANOVA was repeated for all salivary biomarkers, including alpha-amylase, 
cortisol, and the four cytokine markers. A significant difference (p < 0.1) between changes in the 
verum condition compared to sham would result in a rejection of the null hypothesis.  
Secondary Outcomes. To investigate other possible variables influencing stress and stimulation 
response, a correlational analysis was conducted to determine if scores on the CDRISC, STAI 
Trait, or PSS were associated with physiological changes. The difference was calculated between 
the log-adjusted change in the verum condition and sham condition for each participant; a 
Pearson’s R correlational analysis was then conducted comparing these differences in each of the 
salivary markers with the scores on the three survey measures. A significant difference (p < 0.05) 
would result in a rejection of the null hypothesis.  
Blinding and Safety Measures. To ensure blinding, a chi-squared analysis was conducted 
comparing responses to the participant blinding survey with the true condition order. A separate 
analysis was conducted for each session to account for any order effects. A significant difference 
(p < 0.05) would result in a rejection of the null hypothesis, indicating blinding was not 
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successful. Additionally, a one-way ANOVA was conducted using the factor condition (verum 
or sham) for all side effect ratings. A significant difference (p < 0.05) would result in a rejection 
of the null hypothesis, indicating a difference between the two groups in producing side effects.   
 
Results 
Primary Outcomes 
A 2 x 2 ANOVA comparing the effects of session and condition yielded a significant 
main effect of condition for alpha amylase, F(1,18) = 4.40, η2 = 0.11, p = 0.05. As shown in 
Figure 2, the average change in alpha amylase during the verum stimulation condition (M = -
0.043, SD = 0.18) was significantly lower than the average change during sham stimulation (M = 
0.081, SD = 0.18), indicating decreased SNS activation in the verum condition. The same 
ANOVA model also yielded a significant main effect of condition on IL6, F(1,18) = 4.90, η2 = 
0.10, p = 0.04, and IL8, F(1,18) = 3.25, η2 = 0.05, p = 0.09. Figures 3 and 4 respectively 
illustrate that the average change in both markers was significantly lower in the verum condition 
(M = -0.003, SD = 0.13; M = 0.08, SD = 0.19) compared to sham (M = 0.10, SD = 0.17; M = 
0.16, SD = 0.18).  
There was no significant main effect of condition on cortisol, F(1,18) = 0.07, η2 < 0.01, p 
> 0.1, IL1-beta, F(1,18) = 1.34, η2 = 0.02, p > 0.1, or TNF-alpha, F(1,18) = 2.67, η2 = 0.07, p > 
0.1, such that the average change was the same for each marker during verum stimulation 
(cortisol: M = -0.07, SD = 0.19; IL1-beta: M = 0.09, SD = 0.17; TNF-alpha: M = 0.02, SD = 
0.18) and sham stimulation (cortisol: M = -0.06, SD = 0.14; IL1-beta: M = 0.14, SD = 0.18; TNF-
alpha: M = 0.11, SD = 0.17). Additionally, there was no significant main effect of session on 
cortisol, F(1,18) = 0.01, η2 < 0.01, p > 0.1, alpha amylase, F(1,18) = 0.16, η2 < 0.01, p > 0.1, 
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IL1-beta, F(1,18) = 1.26, η2 = 0.02, p > 0.1, IL6, F(1,18) = 0.004, η2 < 0.01, p > 0.1, IL8, 
F(1,18) = 0.03, η2 < 0.01, p > 0.1, or TNF-alpha, F(1,18) = 0.10, η2 < 0.01, p > 0.1, such that the 
average change was the same in Session 1 (cortisol: M = -0.05, SD = 0.17; alpha amylase: M = 
0.007, SD = 0.19; IL1-beta: M = 0.14, SD = 0.21; IL6: M = 0.05, SD = 0.18; IL8: M = 0.11, SD = 
0.22; TNF-alpha: M = 0.06, SD = 0.21) and Session 2 (cortisol: M = -0.07, SD = 0.16; alpha 
amylase: M = 0.03, SD = 0.19; IL1-beta: M = 0.09, SD = 0.13; IL6: M = 0.05, SD = 0.13; IL8: M 
= 0.12, SD = 0.14; TNF-alpha: M = 0.08, SD = 0.14). 
Finally, there was no significant interaction effect of session and condition for cortisol, 
F(1,18) = 1.38, η2 = 0.05, p > 0.1, alpha amylase, F(1,18) = 0.02, η2 < 0.01, p > 0.1, IL1-beta, 
F(1,18) = 1.12, η2 = 0.04, p > 0.1, IL6, F(1,18) = 2.15, η2 = 0.06, p > 0.1, IL8, F(1,18) = 0.65, η2 
= 0.02, p > 0.1, or TNF-alpha, F(1,18) = 1.08, η2 = 0.03, p > 0.1. Therefore, the sequence did not 
influence changes in any of the physiological measures. Please see Table 2 for a complete 
summary of these results. 
Secondary Outcomes 
A Pearson’s R correlational analysis revealed a moderate negative correlation between 
CDRISC scores and the difference in IL1-beta between sham and verum stimulation conditions 
r(18) = -0.49, p = 0.03. The same model revealed a moderate positive correlation between PSS 
scores and the difference in IL1-beta between sham and verum stimulation conditions r(18) = 
0.49, p = 0.03. Scores on the CDRISC were not correlated with cortisol, r(18) = -0.27, p > 0.1, 
alpha amylase, r(18) = 0.06, p > 0.1, IL6, r(18) = 0.004, p > 0.1, IL8, r(18) = 0.07, p > 0.1, or 
TNF-alpha, r(18) = -0.09, p > 0.1. Scores on the STAI Trait were not correlated with cortisol, 
r(18) = 0.29, p > 0.1, alpha amylase, r(18) = 0.36, p > 0.1, IL1-beta, r(18) = 0.21, p > 0.1, IL6, 
r(18) = 0.13, p > 0.1, IL8, r(18) = 0.38, p > 0.1, or TNF-alpha, r(18) = 0.39, p > 0.1. Finally, 
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scores on the PSS were not correlated with cortisol, r(18) = 0.37, p > 0.1, alpha amylase, r(18) = 
0.38, p > 0.1, IL6, r(18) = 0.13, p > 0.1, IL8, r(18) = 0.17, p > 0.1, or TNF-alpha, r(18) = 0.03, p 
> 0.1. Please see Table 3 for a complete summary of these results. 
Blinding and Safety Measures 
A chi-squared analysis revealed no significant effect of stimulation condition on 
participants’ guesses on the blinding questionnaire in either Session 1, X2(1, N = 20) = 2.14, p = 
0.14, or Session 2, X
2
(1, N = 20) = 0.81, p = 0.37. A one-way ANOVA revealed no significant 
effect of condition on any of the reported side effects, such that reported side effects were on 
average the same at both sessions regardless of stimulation condition. A summary of these 
findings can be found in Table 4.  
  
Discussion 
Markers of Stress 
 The results of the ANOVA demonstrated an effect of condition on alpha amylase that 
supports the main hypothesis, as SNS activation during the sham condition was higher on 
average than during the verum condition. The average alpha amylase change during the verum 
condition was less than zero, meaning individuals generally had higher levels at the start of 
stimulation compared to after stimulation. A possible explanation for this finding is that 
sympathetic activation was high at the time of the first saliva sample for both conditions, but 
only the verum stimulation reduced SNS activity over the forty minutes while sham stimulation 
did not. This explanation supports the hypothesized effect of alpha oscillations in reducing a 
stress response.  
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 Unlike alpha amylase, cortisol did not show any changes in response to stimulation 
condition or session. However, the larger time scale of change associated with HPA axis 
activation could explain why no differences were seen. Given the relationship between SNS and 
HPA axis activation, as well as the changes seen in IL6 and IL8, it is possible that changes in 
cortisol may have been observed from a saliva sample taken at a later time point. Finally, there 
was no effect of session or sequence on changes in either marker of stress, further supporting the 
initial hypothesis that stimulation would influence these markers independent of session order. 
Markers of Immunity 
 Of the four markers of the cytokine panel, only IL6 and IL8 showed changes. These two 
markers changed as expected and in the same direction as alpha amylase such that sham 
stimulation generated a greater increase in both compared to verum stimulation. This result 
supports previous research concerning the relationship between SNS activation and cytokine 
levels. 
 The other two markers, IL1-beta and TNF-alpha, did not show any changes in either 
condition. However, the effects of SNS activation on these markers are less clear than on IL6 and 
IL8; while some studies have shown increases in both in response to stress, others have 
demonstrated a decrease in these cytokines during global SNS activation (Elenkov & Chrousos, 
2002). Therefore, it is possible that individual participants responded differently to the 
stimulation such that no clear trend was observed in IL1-beta and TNF-alpha levels. Similar to 
the stress markers, there was no effect of session or sequence on any of the cytokines, indicating 
that stimulation was effective for IL6 and IL8 regardless of the order in which participants 
received the conditions. 
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Survey Measures and Physiological Changes 
 Surprisingly, only one physiological marker was correlated with any of the survey 
measures, despite other research suggesting a relationship between alpha amylase and the STAI-
Trait (Nater et al, 2007). However, most participants scored in the non-clinical range of the 
STAI-Trait, which may explain why there was no correlation between scores on this form and 
alpha-amylase levels. IL1-beta was negatively correlated with scores on the CDRISC, and 
positively correlated with scores on the PSS. Given the previously established negative 
correlation between scores on the CDRISC and PSS, these results support the inverse 
relationship between resiliency and stress as well as provide another possible explanation for the 
nonsignificant finding of the initial analysis. The negative correlation between IL1-beta and the 
CDRISC means that people with higher resilience are less likely to experience a difference in 
IL1-beta levels between sham and verum conditions, while the positive correlation between IL-
beta and the PSS suggests the opposite for people who experience greater perceived stress.  
Blinding and Safety Measures 
 The chi-squared analysis indicated that participants’ guesses as to whether or not they 
were stimulated were independent of the actual stimulation condition; therefore, blinding was 
successful in both sessions. Additionally, the one-way ANOVA revealed no difference in 
reported side effects at either session, meaning the verum condition did not cause any adverse 
events. These results verify the safety of tACS as a noninvasive method of electrical stimulation.   
Limitations 
As with all research, this study is not without limitations. The sample size of 20 is small, 
and the homogeneity of the sample as mostly male and college-age may have had an impact on 
the results. Additionally, this study did not include a stress task because it was intended to 
TACS AND THE STRESS-IMMUNE RESPONSE        17 
investigate the effects of stimulation on stress without artificially producing a stress response; 
however, the lack of stress task introduced the possibility of a floor effect where individuals 
already at baseline could not decrease further. Finally, although participants were asked to 
maintain regular sleep schedules and refrain from consuming alcohol or caffeine in the 24 hours 
prior to each of their sessions, there was no way to prove they had complied or to account for 
other extraneous variables like exams or other life events that may have influenced stress.  
Summary and Implications 
The results of this study build upon prior research establishing a relationship between 
stress and immunity to suggest a top-down mechanism by which this relationship can be 
mediated. Given that this was a pilot study with a small sample, additional research should be 
conducted to further explore the effects of tACS-induced alpha oscillations on the stress-immune 
response. Including a lab-induced stressor or external event like academic examinations would 
aid in understanding the effects of induced oscillations specifically during times of high stress; 
additionally, adding a later time point to test for cortisol might reveal an effect on HPA axis 
activation. This study design could also be applied to clinical populations, such as individuals 
with anxiety, who experience higher than average SNS activation and could benefit from the 
application of tACS as a treatment mechanism. The findings of this research add to the existing 
body of literature concerning stress and immune activity, and introduce an external method of 
targeting stress and immune responses with implications for further mechanistic understandings 
of the relationship and possible treatment paradigms for clinical populations.  
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Table 1 
 
Sample Characteristics 
Variable Mean (SD) Range 
Age (years) 23.2 (6.76) 18-40 
BMI (kg/m
2
) 24.22 (3.76) 18.7-34.3 
STAI Trait 33.75 (7.38) 21-48 
CDRISC 73.15 (8.72) 58-87 
PSS 11.15 (4.08) 6-22 
Notes: N=20 
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Table 2 
 
Condition x Session Analysis of Variance for Salivary Markers 
Source df F η
 2
 p 
Main Effect: Condition     
     Cortisol 1 0.07 < 0.01 > 0.1 
     Alpha Amylase 1 4.40* 0.11 0.05* 
     IL1 Beta 1 1.34 0.02 > 0.1 
     IL6 1 4.90** 0.10 0.04** 
     IL8 1 3.25* 0.05 0.09* 
     TNF Alpha 1 2.67 0.07 > 0.1 
Main Effect: Session     
     Cortisol 1 0.014 < 0.01 > 0.1 
     Alpha Amylase 1 0.16 < 0.01 > 0.1 
     IL1 Beta 1 1.26 0.02 > 0.1 
     IL6 1 0.004 < 0.01 > 0.1 
     IL8 1 0.03 < 0.01 > 0.1 
     TNF Alpha 1 0.10 < 0.01 > 0.1 
Interaction Effect: Session x Condition     
     Cortisol 1 1.38 0.05 > 0.1 
     Alpha Amylase 1 0.02 < 0.01 > 0.1 
     IL1 Beta 1 1.12 0.04 > 0.1 
     IL6 1 2.15 0.06 > 0.1 
     IL8 1 0.65 0.02 > 0.1 
     TNF Alpha 1 1.08 0.03 > 0.1 
 
Notes: * = p < 0.1   ** = p < 0.05. N=20. 
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Table 3 
 
Pearson’s Product Moment Correlations for Salivary Markers and Survey Measures 
 Cortisol 
Alpha 
Amylase 
IL1 IL6 IL8 
TNF 
Alpha 
CDRISC -0.27 0.056 -0.49** 0.0037 0.070 -0.093 
STAI  0.29 0.36 0.21 0.13 0.38 0.39 
PSS 0.37 0.38 0.49** 0.13 0.17 0.028 
 
Notes: * = p < 0.1   ** = p < 0.05. N=20. 
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Table 4 
 
One-Way Analysis of Variance for Safety Measures 
Source df SS MS F 
Condition     
     Headache 1 0.1 0.1 0.22 
     Neck Pain 1 0.1 0.1 0.69 
     Scalp Pain 1 0.1 0.1 0.27 
     Tingling 1 0.1 0.1 0.28 
     Itching 1 0.4 0.4 0.65 
     Ringing 1 0.03 0.03 1 
Burning 1 0.23 0.23 0.39 
Redness 1 0.03 0.03 1 
Sleepiness 1 0.85 0.85 0.91 
Trouble Concentrating 1 0.03 0.03 0.04 
Improved Mood 1 0.0 0.0 0 
Worsened Mood 1 1.5 x 10
-30
 1.5 x 10
-30
 1 
Dizziness 1 0.1 0.1 0.69 
Flickering Lights 1 0.4 0.4 0.60 
Residual     
     Headache 38 17.0 0.45  
     Neck Pain 38 5.5 0.38  
     Scalp Pain 38 14.3 0.02  
     Tingling 38 13.8 0.36  
     Itching 38 23.5 0.62  
     Ringing 38 0.95 0.03  
Burning 38 21.8 0.57  
Redness 38 0.95 0.03  
Sleepiness 38 34.6 0.93  
Trouble Concentrating 38 22.0 0.58  
Improved Mood 38 1.9 0.05  
Worsened Mood 38 5.7 x 10
-29
 1.5 x 10
-30
  
Dizziness 38 5.5 0.14  
Flickering Lights 38 25.2 0.66  
Total     
     Headache 39 17.1 0.44  
     Neck Pain 39 5.6 0.14  
     Scalp Pain 39 14.4 0.37  
     Tingling 39 13.9 0.36  
     Itching 39 23.9 0.61  
     Ringing 39 0.95 0.02  
Burning 39 22.0 0.56  
Redness 39 0.95 0.02  
Sleepiness 39 35.5 0.9  
Trouble Concentrating 39 22.0 0.56  
Improved Mood 39 1.9 0.05  
Worsened Mood 39 5.8 x 10
-29
 1.5 x 10
-30
  
Dizziness 39 5.6 0.14  
Flickering Lights 39 25.6 0.66  
 
Notes: N = 20 
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Figure Captions 
Figure 1. tACS Electrode Placement 
Figure 2. Log-Adjusted Change in Alpha Amylase by Condition 
Figure 3. Log-Adjusted Change in IL6 by Condition 
Figure 4. Log-Adjusted Change in IL8 by Condition  
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